DividendJul 10, 2026, 08:01 AM
VYNE Therapeutics Declares $0.38/Share Special Cash Dividend
AI Summary
VYNE Therapeutics Inc. announced a special cash dividend of an estimated $0.38 per share, totaling approximately $16.5 million. This dividend is in connection with the previously announced merger with Yarrow Bioscience, Inc. The dividend will be payable to stockholders and warrant holders of record as of July 22, 2026, with the payment scheduled for July 23, 2026. The payment is contingent upon the closing of the merger, which is expected around July 24, 2026, pending stockholder approval at a special meeting on July 16, 2026.
Key Highlights
- VYNE Therapeutics declared a special cash dividend.
- Estimated aggregate dividend of $16.5 million.
- Estimated dividend of $0.38 per share.
- Payable to stockholders and warrant holders of record as of July 22, 2026.
- Dividend payment date scheduled for July 23, 2026.
- Payment is conditioned upon the closing of the merger with Yarrow Bioscience.
- Merger closing expected on or about July 24, 2026.
- Stockholders to vote on merger approval on July 16, 2026.
Price Impact
More from VYNE